{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T04:07:10Z","timestamp":1746677230422,"version":"3.40.5"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03094-8","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T03:42:18Z","timestamp":1743738138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["QbD-Based Development of Fluocinolone Nanocomposite Transdermal Gel: Optimization, Characterization, and Enhanced Anti-hyperpigmentation Efficacy Assessment"],"prefix":"10.1208","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7218-5014","authenticated-orcid":false,"given":"Priyanka","family":"Rathore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8463-0613","authenticated-orcid":false,"given":"Rishikesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9404-2947","authenticated-orcid":false,"given":"Prem Prakash","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3131-4320","authenticated-orcid":false,"given":"Anshu","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4118-1998","authenticated-orcid":false,"given":"Ankita","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8782-6689","authenticated-orcid":false,"given":"Kuldeep K.","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8017-9722","authenticated-orcid":false,"given":"Alok Kumar","family":"Mahor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"3094_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.fsc.2011.05.010","volume":"19","author":"AM Rossi","year":"2011","unstructured":"Rossi AM, Perez MI. Treatment of hyperpigmentation. Facial Plast Surg Clin North Am. 2011;19:313\u201324.","journal-title":"Facial Plast Surg Clin North Am"},{"key":"3094_CR2","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.3390\/molecules28124839","volume":"28","author":"AM Thawabteh","year":"2023","unstructured":"Thawabteh AM, Jibreen A, Karaman D, Thawabteh A, Karaman R. Skin Pigmentation Types, Causes and Treatment-A Review. Molecules. 2023;28:4839.","journal-title":"Molecules"},{"key":"3094_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1468-3083.1995.tb00341.x","volume":"4","author":"A Katsambas","year":"1995","unstructured":"Katsambas A, Antoniou C. Melasma. Classification and treatment. J Eur Acad Dermatol Venereol. 1995;4:217\u201323.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3094_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s40257-017-0333-6","volume":"19","author":"BP Kaufman","year":"2018","unstructured":"Kaufman BP, Aman T, Alexis AF. Postinflammatory hyperpigmentation: epidemiology, clinical presentation, pathogenesis and treatment. Am J Clin Dermatol. 2018;19:489\u2013503.","journal-title":"Am J Clin Dermatol"},{"key":"3094_CR5","unstructured":"Baumann L, Beach M, Sogol Saghari F, Editor A, York Chicago San Francisco Lisbon London Madrid Mexico City Milan New Delhi San Juan N. Cosmetic dermatology. 2nd ed. Leslie Baumann, Sogol Saghari EW, editor. Mc Graw Hill; 2009."},{"issue":"5","key":"3094_CR6","doi-asserted-by":"publisher","first-page":"S262","DOI":"10.1016\/j.jaad.2005.12.043","volume":"54","author":"JP Ortonne","year":"2006","unstructured":"Ortonne JP, Pandya AG, Lui H, Hexsel D. Treatment of solar lentigines. J Am Acad Dermatol. 2006;54(5):S262\u201371.","journal-title":"J Am Acad Dermatol"},{"key":"3094_CR7","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.1111\/j.1468-3083.2012.04685.x","volume":"27","author":"K Ezzedine","year":"2013","unstructured":"Ezzedine K, Mauger E, Latreille J, Jdid R, Malvy D, Gruber F, et al. Freckles and solar lentigines have different risk factors in Caucasian women. J Eur Acad Dermatol Venereol. 2013;27:e345\u201356.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3094_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/cosmetics6040057","volume":"6","author":"L Panzella","year":"2019","unstructured":"Panzella L, Napolitano A. Natural and Bioinspired Phenolic Compounds as Tyrosinase Inhibitors for the Treatment of Skin Hyperpigmentation: Recent Advances. Cosmetics. 2019;6:57.","journal-title":"Cosmetics"},{"key":"3094_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2165\/00128071-200001050-00001","volume":"1","author":"A P\u00e9rez-Bernal","year":"2000","unstructured":"P\u00e9rez-Bernal A, Mu\u00f1oz-P\u00e9rez MA, Camacho F. Management of facial hyperpigmentation. Am J Clin Dermatol. 2000;1:261\u20138.","journal-title":"Am J Clin Dermatol"},{"key":"3094_CR10","doi-asserted-by":"publisher","first-page":"1800313","DOI":"10.1002\/ejlt.201800313","volume":"121","author":"U Goik","year":"2019","unstructured":"Goik U, Goik T, Za\u0142\u0119ska I. The properties and application of argan oil in cosmetology. Eur J Lipid Sci Technol. 2019;121:1800313.","journal-title":"Eur J Lipid Sci Technol"},{"key":"3094_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s13346-021-00988-5","volume":"12","author":"SC Yeoh","year":"2021","unstructured":"Yeoh SC, Goh CF. Topical delivery of salicylates. Drug Deliv Transl Res. 2021;12:981\u20131001.","journal-title":"Drug Deliv Transl Res"},{"key":"3094_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.4103\/0019-5154.57602","volume":"54","author":"D Bandyopadhyay","year":"2009","unstructured":"Bandyopadhyay D. Topical treatment of Melasma. Indian J Dermatol. 2009;54:303.","journal-title":"Indian J Dermatol"},{"key":"3094_CR13","first-page":"415","volume":"9","author":"K Katarzyna","year":"2019","unstructured":"Katarzyna K, Agata W, Anna F-D, Monika S, Agnieszka W, Inga J-F, et al. Laser removal of tattoo-A case report. J Educ Heal Sport. 2019;9:415\u20139.","journal-title":"J Educ Heal Sport"},{"key":"3094_CR14","doi-asserted-by":"publisher","first-page":"520","DOI":"10.4103\/0019-5154.164416","volume":"60","author":"T Padhi","year":"2015","unstructured":"Padhi T, Pradhan S. Oral tranexamic acid with fluocinolone-based triple combination cream versus fluocinolone-based triple combination cream alone in melasma: an open labeled randomized comparative trial. Indian J Dermatol. 2015;60:520.","journal-title":"Indian J Dermatol"},{"key":"3094_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1159\/000251347","volume":"151","author":"J Arnold","year":"1975","unstructured":"Arnold J, Anthonioz P, Marchand JP. Depigmenting action of corticosteroidsexperimental study on guinea pigs. Dermatology. 1975;151:274\u201380.","journal-title":"Dermatology"},{"key":"3094_CR16","doi-asserted-by":"crossref","unstructured":"Abed SN, Deb PK, Surchi HS, Kokaz SF, Jamal SM, Bandopadhyay S, et al. Nanocarriers in Different Preclinical and Clinical Stages. Basic Fundam Drug Deliv. Academic Press; 2019. p. 685\u2013731.","DOI":"10.1016\/B978-0-12-817909-3.00017-0"},{"issue":"1","key":"3094_CR17","first-page":"57","volume":"75","author":"HM Torok","year":"2005","unstructured":"Torok HM, Jones T, Rich P, Smith S, Tschen E. Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma. Cutis. 2005;75(1):57\u201362.","journal-title":"Cutis"},{"key":"3094_CR18","doi-asserted-by":"publisher","first-page":"1337282","DOI":"10.3389\/fphar.2024.1337282","volume":"15","author":"P Ghasemiyeh","year":"2024","unstructured":"Ghasemiyeh P, Fazlinejad R, Kiafar MR, Rasekh S, Mokhtarzadegan M, Mohammadi-Samani S. Different therapeutic approaches in melasma: advances and limitations. Front Pharmacol. 2024;15:1337282.","journal-title":"Front Pharmacol"},{"key":"3094_CR19","first-page":"1408","volume":"13","author":"C Ferraris","year":"2021","unstructured":"Ferraris C, Rimicci C, Garelli S, Ugazio E, Battaglia L. Nanosystems in Cosmetic Products: A Brief Overview of Functional, Market. Regulatory Safety Concerns Pharmaceutics. 2021;13:1408.","journal-title":"Regulatory Safety Concerns Pharmaceutics"},{"key":"3094_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11051-022-05534-z","volume":"24","author":"MJ Tangau","year":"2022","unstructured":"Tangau MJ, Chong YK, Yeong KY. Advances in cosmeceutical nanotechnology for hyperpigmentation treatment. J Nanoparticle Res. 2022;24:1\u201318.","journal-title":"J Nanoparticle Res"},{"key":"3094_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/0122150838266844230927052225","volume":"10","author":"PL Pingale","year":"2023","unstructured":"Pingale PL, Patil RA, Bedse AP, Raut SS. Natural Nanoparticulate Cosmeceuticals: Boon for Hyperpigmentation. Curr Tradit Med. 2023;10:1\u201313.","journal-title":"Curr Tradit Med"},{"key":"3094_CR22","doi-asserted-by":"publisher","first-page":"104362","DOI":"10.1016\/j.arabjc.2022.104362","volume":"15","author":"Y Budama-Kilinc","year":"2022","unstructured":"Budama-Kilinc Y, Gok B, Kecel-Gunduz S, Altuntas E. Development of nanoformulation for hyperpigmentation disorders: Experimental evaluations, in vitro efficacy and in silico molecular docking studies. Arab J Chem. 2022;15:104362.","journal-title":"Arab J Chem"},{"key":"3094_CR23","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/pcmr.12986","volume":"34","author":"A Nautiyal","year":"2021","unstructured":"Nautiyal A, Wairkar S. Management of hyperpigmentation: Current treatments and emerging therapies. Pigment Cell Melanoma Res. 2021;34:1000\u201314.","journal-title":"Pigment Cell Melanoma Res"},{"key":"3094_CR24","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1080\/08982104.2021.2024567","volume":"32","author":"RK Farooqui","year":"2022","unstructured":"Farooqui RK, Kaurav M, Kumar M, Sudheesh MS, Pandey RS. Permeation enhancer nanovesicles mediated topical delivery of curcumin for the treatment of hyperpigmentation. J Liposome Res. 2022;32:332\u20139.","journal-title":"J Liposome Res"},{"key":"3094_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3390\/molecules28010220","volume":"28","author":"S Singh","year":"2022","unstructured":"Singh S, Sharma N, Zahoor I, Behl T, Antil A, Gupta S, et al. Decrypting the Potential of Nanotechnology-Based Approaches as Cutting-Edge for Management of Hyperpigmentation Disorder. Molecules. 2022;28:220.","journal-title":"Molecules"},{"issue":"2","key":"3094_CR26","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/polym12020408","volume":"12","author":"P Zhang","year":"2020","unstructured":"Zhang P, Guo H, Liu C. Fabrication of Carboxylmethyl Chitosan Nanocarrier via Self-Assembly for Efficient Delivery of Phenylethyl Resorcinol in B16 Cells. Polymers. 2020;12(2):408.","journal-title":"Polymers"},{"key":"3094_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/21691401.2020.1865993","volume":"49","author":"K Khezri","year":"2021","unstructured":"Khezri K, Saeedi M, Morteza-Semnani K, Akbari J, Hedayatizadeh-Omran A. A promising and effective platform for delivering hydrophilic depigmenting agents in the treatment of cutaneous hyperpigmentation: kojic acid nanostructured lipid carrier. Artif Cells, Nanomedicine, Biotechnol. 2021;49:38\u201347.","journal-title":"Artif Cells, Nanomedicine, Biotechnol"},{"key":"3094_CR28","doi-asserted-by":"publisher","first-page":"111429","DOI":"10.1016\/j.micromeso.2021.111429","volume":"327","author":"Q Du","year":"2021","unstructured":"Du Q, Liu Q. ROS-responsive hollow mesoporous silica nanoparticles loaded with Glabridin for anti-pigmentation properties. Microporous Mesoporous Mater. 2021;327:111429.","journal-title":"Microporous Mesoporous Mater"},{"key":"3094_CR29","doi-asserted-by":"crossref","unstructured":"Sanchez C, Soler-Illia GJDAA, Ribot F, Lalot T, Mayer CR, Cabuil V. Designed hybrid organic-inorganic nanocomposites from functional nanobuilding blocks. Chem Mater. 2001;13:3061\u201383.","DOI":"10.1021\/cm011061e"},{"key":"3094_CR30","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1039\/b509097k","volume":"15","author":"C Sanchez","year":"2005","unstructured":"Sanchez C, Juli\u00e1n B, Belleville P, Popall M. Applications of hybrid organic\u2013inorganic nanocomposites. J Mater Chem. 2005;15:3559\u201392.","journal-title":"J Mater Chem"},{"key":"3094_CR31","doi-asserted-by":"crossref","unstructured":"Rahmani S, Maroufkhani M, Mohammadzadeh-Komuleh S, Khoubi-Arani Z. Polymer nanocomposites for biomedical applications. Fundam Bionanomaterials. 2022;175\u2013215.","DOI":"10.1016\/B978-0-12-824147-9.00007-8"},{"key":"3094_CR32","unstructured":"Thirugnanasambandan T. Bio-nanocomposites in Biomedical Application. In: Muthukumar, C., Thiagamani, S.M.K., Krishnasamy, S., Nagarajan, R., Siengchin S, editor. Compos Sci Technol. Singapore: Springer; 2022. p. 275\u201391."},{"key":"3094_CR33","doi-asserted-by":"publisher","first-page":"7142","DOI":"10.1039\/D3RA08946K","volume":"14","author":"M Shin","year":"2024","unstructured":"Shin M, Lim J, Park Y, Lee JY, Yoon J, Choi JW. Carbon-based nanocomposites for biomedical applications. RSC Adv. 2024;14:7142\u201356.","journal-title":"RSC Adv"},{"key":"3094_CR34","doi-asserted-by":"publisher","first-page":"e10315","DOI":"10.1002\/btm2.10315","volume":"7","author":"S Huang","year":"2022","unstructured":"Huang S, Hong X, Zhao M, Liu N, Liu H, Zhao J, et al. Nanocomposite hydrogels for biomedical applications. Bioeng Transl Med. 2022;7:e10315.","journal-title":"Bioeng Transl Med"},{"issue":"1","key":"3094_CR35","doi-asserted-by":"publisher","first-page":"103629","DOI":"10.1016\/j.isci.2021.103629","volume":"25","author":"W Feng","year":"2021","unstructured":"Feng W, Wang Z. Biomedical applications of chitosan-graphene oxide nanocomposites. iScience. 2021;25(1):103629.","journal-title":"iScience"},{"key":"3094_CR36","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ijbiomac.2020.04.040","volume":"156","author":"H Abd-Allah","year":"2020","unstructured":"Abd-Allah H, Abdel-Aziz RTA, Nasr M. Chitosan nanoparticles making their way to clinical practice: A feasibility study on their topical use for acne treatment. Int J Biol Macromol. 2020;156:262\u201370.","journal-title":"Int J Biol Macromol"},{"key":"3094_CR37","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s13346-018-0508-6","volume":"9","author":"NS Ayumi","year":"2019","unstructured":"Ayumi NS, Sahudin S, Hussain Z, Hussain M, Samah NHA. Polymeric nanoparticles for topical delivery of alpha and beta arbutin: preparation and characterization. Drug Deliv Transl Res. 2019;9:482\u201396.","journal-title":"Drug Deliv Transl Res"},{"key":"3094_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.matchemphys.2018.05.076","volume":"216","author":"K Kosowska","year":"2018","unstructured":"Kosowska K, Domalik-Pyzik P, Nocu\u0144 M, Ch\u0142opek J. Chitosan and graphene oxide\/reduced graphene oxide hybrid nanocomposites \u2013 Evaluation of physicochemical properties. Mater Chem Phys. 2018;216:28\u201336.","journal-title":"Mater Chem Phys"},{"key":"3094_CR39","doi-asserted-by":"crossref","unstructured":"Mahor A, Singh PP, Bharadwaj P, Sharma N, Yadav S, Rosenholm JM, et al. Carbon-Based Nanomaterials for Delivery of Biologicals and Therapeutics: A Cutting-Edge Technology. \u201cC\u201d J Carbon Res. 2021;7:1\u201319.","DOI":"10.3390\/c7010019"},{"key":"3094_CR40","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/smll.201102393","volume":"8","author":"A Sasidharan","year":"2012","unstructured":"Sasidharan A, Panchakarla LS, Sadanandan AR, Ashokan A, Chandran P, Girish CM, et al. Hemocompatibility and macrophage response of pristine and functionalized graphene. Small. 2012;8:1251\u201363.","journal-title":"Small"},{"key":"3094_CR41","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1166\/jbn.2011.1224","volume":"7","author":"NVS Vallabani","year":"2011","unstructured":"Vallabani NVS, Mittal S, Shukla RK, Pandey AK, Dhakate SR, Pasricha R, et al. Toxicity of graphene in normal human lung cells (BEAS-2B). J Biomed Nanotechnol. 2011;7:106\u20137.","journal-title":"J Biomed Nanotechnol"},{"key":"3094_CR42","first-page":"79","volume":"7","author":"M Ul-Islam","year":"2024","unstructured":"Ul-Islam M, Alabbosh KF, Manan S, Khan S, Ahmad F, Ullah MW. Chitosan-based nanostructured biomaterials: Synthesis, properties, and biomedical applications. Adv Ind Eng Polym Res. 2024;7:79\u201399.","journal-title":"Adv Ind Eng Polym Res"},{"key":"3094_CR43","doi-asserted-by":"publisher","first-page":"43629","DOI":"10.1039\/D0RA07640F","volume":"10","author":"P Rathore","year":"2020","unstructured":"Rathore P, Mahor A, Jain S, Haque A, Kesharwani P. Formulation development, in vitro and in vivo evaluation of chitosan engineered nanoparticles for ocular delivery of insulin. RSC Adv. 2020;10:43629\u201339.","journal-title":"RSC Adv"},{"key":"3094_CR44","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.carbpol.2010.10.054","volume":"83","author":"Y Pan","year":"2011","unstructured":"Pan Y, Wu T, Bao H, Li L. Green fabrication of chitosan films reinforced with parallel aligned graphene oxide. Carbohydr Polym. 2011;83:1908\u201315.","journal-title":"Carbohydr Polym"},{"key":"3094_CR45","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.3390\/ma14092351","volume":"14","author":"Z Su","year":"2021","unstructured":"Su Z, Sun D, Zhang L, He M, Jiang Y, Millar B, et al. Chitosan\/silver nanoparticle\/graphene oxide nanocomposites with multi-drug release, antimicrobial, and photothermal conversion functions. Materials (Basel). 2021;14:2351.","journal-title":"Materials (Basel)"},{"key":"3094_CR46","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.3390\/nano12234261","volume":"12","author":"S Eltahir","year":"2022","unstructured":"Eltahir S, Al homsi R, Jagal J, Ahmed IS, Haider M. Graphene oxide\/chitosan injectable composite hydrogel for controlled release of doxorubicin: an approach for enhanced intratumoral delivery. Nanomaterials. 2022;12:4261.","journal-title":"Nanomaterials"},{"key":"3094_CR47","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ijbiomac.2022.12.291","volume":"229","author":"MFP Gra\u00e7a","year":"2023","unstructured":"Gra\u00e7a MFP, Melo BL, Lima-Sousa R, Ferreira P, Moreira AF, Correia IJ. Reduced graphene oxide-enriched chitosan hydrogel\/cellulose acetate-based nanofibers application in mild hyperthermia and skin regeneration. Int J Biol Macromol. 2023;229:224\u201335.","journal-title":"Int J Biol Macromol"},{"key":"3094_CR48","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/jfb14120556","volume":"14","author":"A Moeinzadeh","year":"2023","unstructured":"Moeinzadeh A, Ashtari B, Garcia H, Koruji M, Velazquez CA, Bagher Z, et al. The Effect of Chitosan\/Alginate\/Graphene Oxide Nanocomposites on Proliferation of Mouse Spermatogonial Stem Cells. J Funct Biomater. 2023;14:556.","journal-title":"J Funct Biomater"},{"key":"3094_CR49","doi-asserted-by":"publisher","first-page":"7776","DOI":"10.3390\/app11177776","volume":"11","author":"S Moradi","year":"2021","unstructured":"Moradi S, Hamedi H, Tonelli AE, King MW. Chitosan\/Graphene Oxide Composite Films and Their Biomedical and Drug Delivery Applications: A Review. Appl Sci. 2021;11:7776.","journal-title":"Appl Sci"},{"key":"3094_CR50","doi-asserted-by":"publisher","first-page":"109557","DOI":"10.1016\/j.compositesb.2021.109557","volume":"231","author":"SM Hosseini","year":"2022","unstructured":"Hosseini SM, Abdouss M, Mazinani S, Soltanabadi A, Kalaee M. Modified nanofiber containing chitosan and graphene oxide-magnetite nanoparticles as effective materials for smart wound dressing. Compos Part B Eng. 2022;231:109557.","journal-title":"Compos Part B Eng"},{"key":"3094_CR51","doi-asserted-by":"publisher","first-page":"118345","DOI":"10.1016\/j.carbpol.2021.118345","volume":"269","author":"Y Li","year":"2021","unstructured":"Li Y, Yang Y, Shao Y, Sun Y, Si H, Miao J, et al. Chitosan functionalized graphene oxide nanocomposites for fluorescence imaging of apoptotic processes and targeted anti-inflammation study. Carbohydr Polym. 2021;269:118345.","journal-title":"Carbohydr Polym"},{"key":"3094_CR52","doi-asserted-by":"crossref","unstructured":"Wro\u0144ska N, Anouar A, Achaby M El, Zawadzka K, K\u0229dzierska M, Milowska K, et al. Chitosan-Functionalized Graphene Nanocomposite Films: Interfacial Interplay and Biological Activity. Materials (Basel). 2020;13(4):998.","DOI":"10.3390\/ma13040998"},{"key":"3094_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10965-024-04064-7","volume":"31","author":"SS Aljelawy","year":"2024","unstructured":"Aljelawy SS, Al-Bermany E, Abdulridha AR. Performance of graphene-functionalized nano chitosan in ternary polymeric nanocomposites for physical and biological applications. J Polym Res. 2024;31:1\u201315.","journal-title":"J Polym Res"},{"key":"3094_CR54","doi-asserted-by":"publisher","first-page":"106033","DOI":"10.1016\/j.jmbbm.2023.106033","volume":"145","author":"A Sanmugam","year":"2023","unstructured":"Sanmugam A, Abbishek S, Kumar SL, Sairam AB, Palem VV, Kumar RS, et al. Synthesis of chitosan based reduced graphene oxide-CeO2 nanocomposites for drug delivery and antibacterial applications. J Mech Behav Biomed Mater. 2023;145:106033.","journal-title":"J Mech Behav Biomed Mater"},{"key":"3094_CR55","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.ijbiomac.2020.02.053","volume":"150","author":"TS Anirudhan","year":"2020","unstructured":"Anirudhan TS, Chithra Sekhar V, Athira VS. Graphene oxide based functionalized chitosan polyelectrolyte nanocomposite for targeted and pH responsive drug delivery. Int J Biol Macromol. 2020;150:468\u201379.","journal-title":"Int J Biol Macromol"},{"key":"3094_CR56","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2147\/IJN.S240305","volume":"2020","author":"T Figueroa","year":"2020","unstructured":"Figueroa T, Aguayo C, Fern\u00e1ndez K. Design and Characterization of Chitosan-Graphene Oxide Nanocomposites for the Delivery of Proanthocyanidins. Int J Nanomedicine. 2020;2020:1229\u201338.","journal-title":"Int J Nanomedicine"},{"key":"3094_CR57","doi-asserted-by":"publisher","first-page":"2300177","DOI":"10.1002\/adtp.202300177","volume":"6","author":"M Kourti","year":"2023","unstructured":"Kourti M, Theodorakis A, Skouras A, Chrissopoulou K, Anastasiadis SH, Stylianakis MM. Capitalization of Graphene\/Chitosan Nanocomposites as Intriguing Vehicles for Targeted Anti-Cancer Drug Delivery. Adv Ther. 2023;6:2300177.","journal-title":"Adv Ther"},{"key":"3094_CR58","first-page":"1129","volume":"63","author":"P Chhabra","year":"2024","unstructured":"Chhabra P, Chauhan G, Gupta A, Tripathy D, Tyagi A, Chauhan R. Encapsulated iodine\u2013chitosan graphene oxide nanocomposite: fabrication and evaluation for antibacterial activity. Polym Technol Mater. 2024;63:1129\u201342.","journal-title":"Polym Technol Mater"},{"key":"3094_CR59","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3390\/antibiotics13070620","volume":"13","author":"A Ortega-Ramirez","year":"2024","unstructured":"Ortega-Ramirez A, Fernando Ayala-Zavala J, Sanmugam A, Kumar Sellappan L, Sridharan A, Manoharan S, et al. Chitosan-Integrated Curcumin-Graphene Oxide\/Copper Oxide Hybrid Nanocomposites for Antibacterial and Cytotoxicity Applications. Antibiotics. 2024;13:620.","journal-title":"Antibiotics"},{"key":"3094_CR60","doi-asserted-by":"publisher","first-page":"128832","DOI":"10.1016\/j.ijbiomac.2023.128832","volume":"258","author":"N Elhami","year":"2024","unstructured":"Elhami N, Pazhang M, Beygi-khosrowshahi Y, Dehghani A. Development of nanocomposites based on chitosan\/reduced graphene oxide for wound healing application. Int jJurnal Biol Macromol. 2024;258:128832.","journal-title":"Int jJurnal Biol Macromol"},{"key":"3094_CR61","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ijbiomac.2020.03.095","volume":"154","author":"J Prakash","year":"2020","unstructured":"Prakash J, Prema D, Venkataprasanna KS, Balagangadharan K, Selvamurugan N, Venkatasubbu GD. Nanocomposite chitosan film containing graphene oxide\/hydroxyapatite\/gold for bone tissue engineering. Int J Biol Macromol. 2020;154:62\u201371.","journal-title":"Int J Biol Macromol"},{"key":"3094_CR62","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.snb.2013.05.014","volume":"185","author":"A Singh","year":"2013","unstructured":"Singh A, Sinsinbar G, Choudhary M, Kumar V, Pasricha R, Verma HN, et al. Graphene oxide-chitosan nanocomposite based electrochemical DNA biosensor for detection of typhoid. Sensors Actuators B Chem. 2013;185:675\u201384.","journal-title":"Sensors Actuators B Chem"},{"key":"3094_CR63","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.3390\/polym13193266","volume":"13","author":"R Ikram","year":"2021","unstructured":"Ikram R, Jan BM, Qadir MA, Sidek A, Stylianakis MM, Kenanakis G. Recent Advances in Chitin and Chitosan\/Graphene-Based Bio-Nanocomposites for Energetic Applications. Polymers (Basel). 2021;13:3266.","journal-title":"Polymers (Basel)"},{"key":"3094_CR64","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1021\/ja01539a017","volume":"80","author":"WS Hummers","year":"1958","unstructured":"Hummers WS, Offeman RE. Preparation of Graphitic Oxide. J Am Chem Soc. 1958;80:1339.","journal-title":"J Am Chem Soc"},{"key":"3094_CR65","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.carbpol.2013.12.012","volume":"103","author":"R Justin","year":"2014","unstructured":"Justin R, Chen B. Characterisation and drug release performance of biodegradable chitosan\u2013graphene oxide nanocomposites. Carbohydr Polym. 2014;103:70\u201380.","journal-title":"Carbohydr Polym"},{"key":"3094_CR66","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3390\/gels8110746","volume":"8","author":"H Raza","year":"2022","unstructured":"Raza H, Shah SU, Ali Z, Khan AU, Rajput IB, Farid A, et al. In Vitro and Ex Vivo Evaluation of Fluocinolone Acetonide\u2013Acitretin-Coloaded Nanostructured Lipid Carriers for Topical Treatment of Psoriasis. Gels. 2022;8:746.","journal-title":"Gels"},{"key":"3094_CR67","unstructured":"Madhulika Pradhan, K. K. Sahu, Deependra Singh, Manju Rawat Singh KY. AU2021106678A4 - A method of preparation of Triamcinolone Acetonide encapsulated nanostructured lipid carriers for psoriasis treatment. - Google Patents. India; 2021. p. 1\u201314."},{"issue":"2","key":"3094_CR68","first-page":"184","volume":"6","author":"M Elmowafy","year":"2017","unstructured":"Elmowafy M, Samy A, Abdelaziz AE, Shalaby K, Salama A, Raslan MA, Abdelgawad MA. Polymeric nanoparticles based topical gel of poorly soluble drug: Formulation, ex-vivo and in vivo evaluation. Beni-Suef Univ J Basic Appl Sci. 2017;6(2):184\u201391.","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"3094_CR69","doi-asserted-by":"publisher","first-page":"292","DOI":"10.9734\/jpri\/2021\/v33i44A32616","volume":"33","author":"K Jadhav","year":"2021","unstructured":"Jadhav K, Jadhav S, Sonawane D, Somvanshi D, Shah H, Patil P, et al. Formulation and Evaluation of Miconazole Nitrate Loaded Novel Nanoparticle Gel for Topical Delivery. J Pharm Res Int. 2021;33:292\u2013307.","journal-title":"J Pharm Res Int"},{"key":"3094_CR70","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.52711\/0974-360X.2023.00372","volume":"16","author":"A Loya","year":"2023","unstructured":"Loya A, Latha K, Shaik NB, Rahman A, Tamkeen J. Formulation and Evaluation of Transdermal Gel loaded with Atenolol. Res J Pharm Technol. 2023;16:2265\u201372.","journal-title":"Res J Pharm Technol"},{"key":"3094_CR71","doi-asserted-by":"crossref","unstructured":"Zaki RM, Ibrahim MA, Alshora DH, El E, Hu X, Zaki RM, et al. Formulation and Evaluation of Transdermal Gel Containing Tacrolimus-Loaded Spanlastics: In Vitro, Ex Vivo and In Vivo Studies. Polymers (Basel). 2022;14:1528.","DOI":"10.3390\/polym14081528"},{"key":"3094_CR72","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1016\/j.xphs.2021.07.008","volume":"110","author":"S Srivastava","year":"2021","unstructured":"Srivastava S, Mahor A, Singh G, Bansal K, Singh PP, Gupta R, et al. Formulation Development, In Vitro and In Vivo Evaluation of Topical Hydrogel Formulation of Econazole Nitrate-Loaded \u03b2-Cyclodextrin Nanosponges. J Pharm Sci. 2021;110:3702\u201314.","journal-title":"J Pharm Sci"},{"key":"3094_CR73","doi-asserted-by":"publisher","first-page":"122","DOI":"10.54133\/ajms.v5i.178","volume":"5","author":"BB Panda","year":"2023","unstructured":"Panda BB, Kala BK, Parmanik A, Kar D, Bose A. Formulation, Development and Evaluation of Sildenafil Citrate Oral Jelly. Al-Rafidain J Med Sci. 2023;5:122\u20136.","journal-title":"Al-Rafidain J Med Sci"},{"issue":"2","key":"3094_CR74","doi-asserted-by":"publisher","first-page":"e0228908","DOI":"10.1371\/journal.pone.0228908","volume":"15","author":"D Hashmat","year":"2020","unstructured":"Hashmat D, Shoaib MH, Ali FR, Siddiqui F. Lornoxicam controlled release transdermal gel patch: Design, characterization and optimization using co-solvents as penetration enhancers. PLoS One. 2020;15(2):e0228908.","journal-title":"PLoS One"},{"key":"3094_CR75","doi-asserted-by":"publisher","first-page":"4819","DOI":"10.3390\/ijms12084819","volume":"12","author":"VCH Lin","year":"2011","unstructured":"Lin VCH, Ding HY, Kuo SY, Chin LW, Wu JY, Chang TS. Evaluation of in Vitro and in Vivo Depigmenting Activity of Raspberry Ketone from Rheum officinale. Int J Mol Sci. 2011;12:4819\u201335.","journal-title":"Int J Mol Sci"},{"key":"3094_CR76","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/biof.1064","volume":"39","author":"KJS Kumar","year":"2013","unstructured":"Kumar KJS, Vani MG, Wang SY, Liao JW, Hsu LS, Yang HL, et al. In vitro and in vivo studies disclosed the depigmenting effects of gallic acid: A novel skin lightening agent for hyperpigmentary skin diseases. BioFactors. 2013;39:259\u201370.","journal-title":"BioFactors"},{"key":"3094_CR77","doi-asserted-by":"publisher","first-page":"125627","DOI":"10.1016\/j.ijbiomac.2023.125627","volume":"246","author":"\u00dcH Erol","year":"2023","unstructured":"Erol \u00dcH, G\u00fcnc\u00fcm E, I\u015f\u0131klan N. Development of chitosan-graphene oxide blend nanoparticles for controlled flurbiprofen delivery. Int J Biol Macromol. 2023;246:125627.","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"3094_CR78","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3390\/pharmaceutics15082025","volume":"15","author":"MY Wu","year":"2023","unstructured":"Wu MY, Kao IF, Fu CY, Yen SK. Effects of Adding Chitosan on Drug Entrapment Efficiency and Release Duration for Paclitaxel-Loaded Hydroxyapatite-Gelatin Composite Microspheres. Pharmaceutics. 2023;15(8):2025.","journal-title":"Pharmaceutics"},{"key":"3094_CR79","first-page":"5","volume":"47","author":"D Sawwashe","year":"2023","unstructured":"Sawwashe D, Chougale RD, Gavande G, Patil KS, Patki S, Disouza J, et al. Design, development, and characterization of posaconazole ethosomal in situ gel. Thai J Pharm Sci. 2023;47:5.","journal-title":"Thai J Pharm Sci"},{"key":"3094_CR80","doi-asserted-by":"crossref","unstructured":"Pandey V, Haider T, Agrawal P, Soni S, Soni V. Advances in Natural Polymeric Nanoparticles for the Drug Delivery. In: Bhupendra G. Prajapati, editor. Adv Drug Deliv Syst. IntechOpen; 2023.","DOI":"10.5772\/intechopen.107513"},{"key":"3094_CR81","doi-asserted-by":"publisher","first-page":"124213","DOI":"10.1016\/j.cej.2020.124213","volume":"388","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, Liu D, Ma J, Chen X. Fluidization of nanoparticle agglomerates assisted by combining vibration and stirring methods. Chem Eng J. 2020;388:124213.","journal-title":"Chem Eng J"},{"key":"3094_CR82","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.ijbiomac.2017.09.096","volume":"107","author":"Z Rao","year":"2018","unstructured":"Rao Z, Ge H, Liu L, Zhu C, Min L, Liu M, et al. Carboxymethyl cellulose modified graphene oxide as pH-sensitive drug delivery system. Int J Biol Macromol. 2018;107:1184\u201392.","journal-title":"Int J Biol Macromol"},{"key":"3094_CR83","doi-asserted-by":"publisher","first-page":"123778","DOI":"10.1016\/j.ijbiomac.2023.123778","volume":"234","author":"MH Alizadeh","year":"2023","unstructured":"Alizadeh MH, Pooresmaeil M, Namazi H. Carboxymethyl cellulose@multi wall carbon nanotubes functionalized with Ugi reaction as a new curcumin carrier. Int J Biol Macromol. 2023;234:123778.","journal-title":"Int J Biol Macromol"},{"key":"3094_CR84","doi-asserted-by":"publisher","first-page":"632698","DOI":"10.1155\/2012\/632698","volume":"2012","author":"LY Ing","year":"2012","unstructured":"Ing LY, Zin NM, Sarwar A, Katas H. Antifungal Activity of Chitosan Nanoparticles and Correlation with Their Physical Properties. Int J Biomater. 2012;2012:632698.","journal-title":"Int J Biomater"},{"key":"3094_CR85","first-page":"265","volume":"12","author":"S Honary","year":"2013","unstructured":"Honary S, Zahir F. Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 2). Trop J Pharm Res. 2013;12:265\u201373.","journal-title":"Trop J Pharm Res"},{"key":"3094_CR86","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1166\/jnn.2007.609","volume":"7","author":"B Sarmento","year":"2007","unstructured":"Sarmento B, Ribeiro AJ, Veiga F, Ferreira DC, Neufeld RJ. Insulin-loaded nanoparticles are prepared by alginate lonotropic pre-gelation followed by chitosan polyelectrolyte complexation. J Nanosci Nanotechnol. 2007;7:2833\u201341.","journal-title":"J Nanosci Nanotechnol"},{"key":"3094_CR87","unstructured":"Brodin B, Steffansen B, Nielsen CU. Passive diffusion of drug substances: the concepts of flux and permeability. In: Bente Steffansen, Birger Brodin CUN, editor. Mol Biopharm Asp drug characterisation, drug Deliv Dos form Eval. Pharmaceutical Press, London; 2010. p. 135\u201351."},{"key":"3094_CR88","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/cosmetics9060114","volume":"9","author":"F Mascarenhas-Melo","year":"2022","unstructured":"Mascarenhas-Melo F, Santos AC, Sahudin S, Ayumi NS, Kaharudin N. Enhancement of Skin Permeation and Penetration of \u03b2-Arbutin Fabricated in Chitosan Nanoparticles as the Delivery System. Cosmetics. 2022;9:114.","journal-title":"Cosmetics"},{"key":"3094_CR89","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1556\/2051.2020.00077","volume":"5","author":"M Budimir","year":"2020","unstructured":"Budimir M, Ska Kleut DU, Markovic BT, Boukherroub R. Reduced graphene oxide-chitosan flexible nanocomposites for efficient bacteria capture and photothermal ablation. Resolut Discov. 2020;5:5\u201312.","journal-title":"Resolut Discov"},{"key":"3094_CR90","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/1523-1747.ep12701679","volume":"62","author":"K Jimbow","year":"1974","unstructured":"Jimbow K, Obata H, Pathak MA, Fitzpatrick TB. Mechanism of Depigmentation by Hydroquinone. J Invest Dermatol. 1974;62:436\u201349.","journal-title":"J Invest Dermatol"},{"key":"3094_CR91","doi-asserted-by":"crossref","unstructured":"Warner MR, Camisa C. Topical corticosteroids. Compr Dermatologic Drug Ther Expert Consult - Online Print. 2013;487\u2013504.e5.","DOI":"10.1016\/B978-1-4377-2003-7.00040-6"},{"key":"3094_CR92","doi-asserted-by":"crossref","unstructured":"Boora K. Fluocinolone. xPharm Compr Pharmacol Ref. 2007;1\u20135.","DOI":"10.1016\/B978-008055232-3.61763-5"},{"key":"3094_CR93","doi-asserted-by":"publisher","first-page":"11289","DOI":"10.3390\/ijms241411289","volume":"24","author":"L Bento-Lopes","year":"2023","unstructured":"Bento-Lopes L, Caba\u00e7o LC, Charneca J, Neto MV, Seabra MC, Barral DC. Melanin\u2019s Journey from Melanocytes to Keratinocytes: Uncovering the Molecular Mechanisms of Melanin Transfer and Processing. Int J Mol Sci. 2023;24:11289.","journal-title":"Int J Mol Sci"},{"key":"3094_CR94","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.3390\/cells11132085","volume":"11","author":"KW Lee","year":"2022","unstructured":"Lee KW, Kim M, Lee SH, Kim KD. The Function of Autophagy as a Regulator of Melanin Homeostasis. Cells. 2022;11:2085.","journal-title":"Cells"},{"key":"3094_CR95","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/pcmr.12838","volume":"33","author":"JY Kim","year":"2020","unstructured":"Kim JY, Kim J, Ahn Y, Lee EJ, Hwang S, Almurayshid A, et al. Autophagy induction can regulate skin pigmentation by causing melanosome degradation in keratinocytes and melanocytes. Pigment Cell Melanoma Res. 2020;33:403\u201315.","journal-title":"Pigment Cell Melanoma Res"},{"key":"3094_CR96","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5114\/pdia.2013.33376","volume":"30","author":"M Cichorek","year":"2013","unstructured":"Cichorek M, Wachulska M, Stasiewicz A, Tymi\u0144ska A. Skin melanocytes: biology and development. Adv Dermatology Allergol Dermatologii I Alergol. 2013;30:30.","journal-title":"Adv Dermatology Allergol Dermatologii I Alergol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03094-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03094-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03094-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T09:04:29Z","timestamp":1746608669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03094-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":96,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["3094"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03094-8","relation":{},"ISSN":["1530-9932"],"issn-type":[{"type":"electronic","value":"1530-9932"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"14 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing financial interests or personal relationships that could have influenced the work presented in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All animal experiments were conducted in full compliance with the Institute of Pharmacy, Bundelkhand University,\u00a0Jhansi, Institutional Animal Ethics Committee (IAEC) guidelines and protocols (Protocol #BU\/Pharma\/IAEC\/A\/23\/05.\u00a0The studies adhered to the principles outlined in the Committee for Control and Supervision of Experiments on\u00a0Animals (CCSEA), and all procedures were performed in accordance with the Animal Research: Reporting of In Vivo\u00a0Experiments (ARRIVE) guidelines. Every effort was made to minimize animal suffering and to reduce the number of\u00a0animals used. The health and welfare of the animals were monitored daily by trained personnel under veterinary\u00a0supervision.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal Ethics Statement"}},{"value":"AI tools (Claude, Perplexity, Google Gemini) assisted in manuscript language refinement.\u00a0Authors reviewed and edited content, ensuring clarity while maintaining full responsibility for publication integrity.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}],"article-number":"100"}}